Georges El‐Hayek
St. Luke's-Roosevelt Hospital Center(US)Roosevelt Hospital(GT)
Publications by Year
Research Areas
Coronary Interventions and Diagnostics, Cardiac Imaging and Diagnostics, Antiplatelet Therapy and Cardiovascular Diseases, Acute Myocardial Infarction Research, Cerebrovascular and Carotid Artery Diseases
Most-Cited Works
- → Meta-Analysis of Randomized Clinical Trials Comparing Biodegradable Polymer Drug-Eluting Stent to Second-Generation Durable Polymer Drug-Eluting Stents(2017)172 cited
- → Safety of catheter‐directed thrombolysis for massive and submassive pulmonary embolism: Results of a multicenter registry and meta‐analysis(2017)105 cited
- → Incidence of cardiovascular events and gastrointestinal bleeding in patients receiving clopidogrel with and without proton pump inhibitors: an updated meta-analysis(2015)85 cited
- → Meta-Analysis of Randomized Clinical Trials Comparing Short-Term Versus Long-Term Dual Antiplatelet Therapy Following Drug-Eluting Stents(2014)73 cited
- → Meta-Analysis of Randomized Controlled Trials Comparing Multivessel Versus Culprit-Only Revascularization for Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease Undergoing Primary Percutaneous Coronary Intervention(2015)51 cited
- → Comparative effectiveness of coronary CT angiography vs stress cardiac imaging in patients following hospital admission for chest pain work-up: The Prospective First Evaluation in Chest Pain (PERFECT) Trial(2016)42 cited
- → Systematic oral hydration with water is similar to parenteral hydration for prevention of contrast-induced nephropathy: an updated meta-analysis of randomised clinical data(2015)41 cited
- → High dose statin loading prior to percutaneous coronary intervention decreases cardiovascular events: A meta‐analysis of randomized controlled trials(2013)39 cited
- → Meta-analysis of coronary computed tomography angiography versus standard of care strategy for the evaluation of low risk chest pain: Are randomized controlled trials and cohort studies showing the same evidence?(2014)23 cited
- → Cilostazol increases patency and reduces adverse outcomes in percutaneous femoropopliteal revascularisation: a meta-analysis of randomised controlled trials(2014)19 cited